AMMONIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ammonium, and what generic alternatives are available?
Ammonium is a drug marketed by Abbott, Gd Searle Llc, Mcgaw, B Braun, Hospira, Padagis Israel, Sun Pharma Canada, Watson Labs Inc, and Zydus Lifesciences. and is included in twelve NDAs.
The generic ingredient in AMMONIUM is ammonium lactate. There are forty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ammonium lactate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ammonium
A generic version of AMMONIUM was approved as ammonium lactate by PADAGIS ISRAEL on May 1st, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMMONIUM?
- What are the global sales for AMMONIUM?
- What is Average Wholesale Price for AMMONIUM?
Summary for AMMONIUM
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 12 |
| Drug Prices: | Drug price information for AMMONIUM |
| Drug Sales Revenues: | Drug sales revenues for AMMONIUM |
| DailyMed Link: | AMMONIUM at DailyMed |


